Cats gain attention as models for virus-linked liver cancer

Version 1

Researchers at City University of Hong Kong are making the case that cats could become important natural models for studying virus-driven liver cancer in people, advancing a One Health approach to oncology. In a January 2026 Nature Reviews Cancer article, Julia Beatty and Thomas Tu argued that feline viruses can offer a useful window into human cancer biology, building in part on a 2025 study showing that domestic cat hepatitis B virus, or DCHBV, was detected in 17 of 71 feline hepatocellular carcinoma cases and in none of 88 control liver samples. That study also found viral DNA integration near the feline CCNE1 proto-oncogene, echoing mechanisms seen in human hepatitis B virus-associated liver cancer. A related CityUHK announcement in April 2026 framed the work as a comparative oncology opportunity that could benefit both feline and human patients. (eurekalert.org)

Why it matters: For veterinary professionals, the story is less about an immediate new clinical tool and more about where feline oncology research may be headed. Cats share human environments, develop cancers naturally rather than in induced lab models, and may help researchers study how chronic viral infection contributes to tumor formation in ways that are more biologically relevant than traditional rodent systems. The underlying disease remains uncommon in practice, with primary liver cancer representing about 1% to 3% of feline malignancies in published studies, but the work could eventually shape screening, biobanking, case recruitment, and translational research partnerships involving veterinary hospitals and diagnostic labs. (sciencedirect.com)

What to watch: Watch for larger multicenter studies, surveillance efforts, and any movement toward standardized testing or sample collection for DCHBV in cats with hepatitis or hepatocellular carcinoma. (eurekalert.org)